Matthew S. Cowlen

Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis

Benjamin R. Yerxa, Juan Sabater, C. William Davis et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 150 citations

Medicine, Molecular Biology, Pharmacology +15

Localization of ocular P2Y2 receptor gene expression by in situ hybridization

Matthew S. Cowlen, Vivian Z. Zhang, Lisa Warnock et al. · Experimental Eye Research · 2003 · 119 citations

Life Sciences, Genetics, Molecular Genetics +5

Fluorescence of .DELTA.5,7,9(11),22-ergostatetraen-3.beta.-ol in micelles, sterol carrier protein complexes, and plasma membranes

Robert T. Fischer, Matthew S. Cowlen, Mary E. Dempsey et al. · Biochemistry · 1985 · 70 citations

Life Sciences, Biochemistry, Molecular Biology +13

Pathogenesis of Experimental Neonatal Woodchuck Hepatitis Virus Infection: Chronicity As An Outcome of Infection Is Associated With A Diminished Acute Hepatitis That Is Temporally Deficient for the Expression of Interferon Gamma and Tumor Necrosis Factor–Alpha Messenger Rnas

Ikuo Nakamura, James T. Nupp, Matthew S. Cowlen et al. · Hepatology · 2001 · 69 citations · Full text

Medicine, Immunology, Pathology +17

Regulation of transbilayer distribution of a fluorescent sterol in tumor cell plasma membranes

Ann B. Kier, William D. Sweet, Matthew S. Cowlen et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1986 · 44 citations

Life Sciences, Biochemistry, Cell Biology +13